Skip to main content

Closed

IMRX: Immuneering Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-0.0%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio32.45×

Immuneering Corporation

IMRXNASDAQ Global Market·USD·Closed

Immuneering Corporation

IMRXNASDAQ·USD·Closed

$4.13

−2.36%

$4.13

−$0.10 (2.36%)

52W Range

17thpctl

Volume

0.27×avg

Mkt Cap

149.93MUSD

P/E

-3.5TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.27×avg

Market Cap

149.93MUSD

P/E Ratio

-3.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings